AlphaFold predicted structure
ROR2 · Q01974

Mean pLDDT
68.3/ 100
Low
943 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)37%
- Low(50–70)8%
- Very low(< 50)32%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ROR family WNT receptor 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
CAKUT
BOTH monoallelic and biallelic, autosomal or pseudoautosomalClefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BOTH monoallelic and biallelic, autosomal or pseudoautosomalFetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIUGR and IGF abnormalities
BIALLELIC, autosomal or pseudoautosomalLimb disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIntellectual disability
BOTH monoallelic and biallelic, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
autosomal recessive Robinow syndrome
brachydactyly type B1
Robinow syndrome
Abnormality of the skeletal system
neurodegenerative disease
brachydactyly type B
brachydactyly
fetal akinesia deformation sequence 1
placenta praevia
arthrogryposis multiplex congenita
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tyrosine-protein kinase transmembrane receptor ROR2
Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development (By similarity). Phosphorylates YWHAB, leading to induction of osteogenesis and bone formation (PubMed:17717073). In contrast, has also been shown to have very little tyrosine kinase activity in vitro. May act as a receptor for wnt ligand WNT5A which may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443)
Curated MONDO disease pages that list ROR2 among their top associated genes.
ROR2 · Q01974

Mean pLDDT
68.3/ 100
Low
943 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0